secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001520138-24-000045
Event type: litigation
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie hit with shareholder class action over NE3107 trial disclosures
----------------------------------------------------------------------

- Lawsuit filed Jan 19, 2024 in Nevada federal court (Olmstead v. BioVie Inc., No. 3:24-cv-00035).
- Alleges material misrepresentations/omissions about NE3107 study and trial under Sections 10(b) and 20(a).
- Class period: Aug 5, 2021 through Nov 29, 2023; seeks unspecified monetary damages and fees.
- Company believes lawsuit is without merit and intends to defend vigorously.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000045/0001520138-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000045/bivi-20240119_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer